ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review

References

• Lu X, Liu Z, Cui Q. et al. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J. 2022;43(18):1702–1711. doi:10.1093/eurheartj/ehac093
   PubMed Web of Science ®Google Scholar
• Tonstad S, Westheim A. Implementation of guidelines to screen relatives of patients with premature coronary heart disease in a hospital setting. Am j Cardiol. 2002;90(11):1211–1214. doi:10.1016/S0002-9149(02)02836-9
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics—2018 update: a Report From the American Heart Association. Circulation. 2018;137:12.
   Web of Science ®Google Scholar
• Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012. doi:10.1093/nar/gky1120
   PubMed Web of Science ®Google Scholar
• Jeon Y, Jeon S, Choi W-H, et al. Genome-wide analyses of early-onset acute myocardial infarction identify 29 novel loci by whole genome sequencing. Hum Genet. 2023;142(2):231–243. doi:10.1007/s00439-022-02495-0
   PubMed Web of Science ®Google Scholar
• Aladag E, Tas Z, Ozdemir BS, et al. Human Ace D/I polymorphism could affect the clinicobiological course of COVID-19. J Renin Angiot Aldoster Sys. 2021;2021:5509280. doi:10.1155/2021/5509280
   PubMed Web of Science ®Google Scholar
• Fawzy MS, Toraih EA, Aly NM, et al. Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. BMC Cardiovasc Disorders. 2017;17(1):26. doi:10.1186/s12872-016-0456-3
   PubMedGoogle Scholar
• Dias‐Filho CAA, Soares NDJS, Bomfim MRQ, et al. The effect of family history of hypertension and polymorphism of the ACE gene (rs1799752) on cardiac autonomic modulation in adolescents. Clin Exp Pharmacol Physiol. 2021;48(2):177–185. doi:10.1111/1440-1681.13426
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Investig. 1990;86(4):1343–1346. doi:10.1172/JCI114844
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Raman G, Kitsios G, et al. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Int Med. 2008;168(10):1077–1089. doi:10.1001/archinte.168.10.1077
   PubMedGoogle Scholar
• Borzyszkowska J, Stanislawska-Sachadyn A, Wirtwein M, et al. Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J Appl Genet. 2012;53(2):175–182. doi:10.1007/s13353-012-0083-3
   PubMed Web of Science ®Google Scholar
• Klashami ZN, Roudbordeh MG, Asadi M, et al. Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience). Mole Biol Rep. 2023;50(8):6445–6455. doi:10.1007/s11033-023-08554-7
   PubMed Web of Science ®Google Scholar
• Poorzand H, Fazeli B, Khajavi O, et al. Association of polymorphisms of renin angiotensin system and endothelial nitric oxide synthase genes with premature cardiovascular disease in an Iranian population. BMC Cardiovasc Disorders. 2023;23(1):254. doi:10.1186/s12872-023-03276-x
   PubMed Web of Science ®Google Scholar
• Masud R, Anjum A, Anwar M, et al. The risk stratification of coronary vascular disease as linked to homocysteine, its modulating genes, genetic polymorphisms, conventional predictors, and with antihypertensive medicaments. Chin J Physiol. 2021;64(6):298. doi:10.4103/cjp.cjp_71_21
   PubMed Web of Science ®Google Scholar
• Presta P, Bolignano D, Coppolino G, et al. Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury. Rev Cardiovasc Med. 2021;22(1):207–213. doi:10.31083/j.rcm.2021.01.288
   PubMed Web of Science ®Google Scholar
• Dai S, Ding M, Liang N, et al. Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients. Sci Rep. 2019;9(1):19719. doi:10.1038/s41598-019-56263-8
   PubMedGoogle Scholar
• Valença-pereira F, Fang Q, Marié IJ, et al. IL-6 enhances CD4 cell motility by sustaining mitochondrial Ca2+ through the noncanonical STAT3 pathway. Proc Natl Acad Sci USA. 2021;118(37):e2103444118. doi:10.1073/pnas.2103444118
   PubMed Web of Science ®Google Scholar
• Kumar V, Prabhu SD, Bansal SS. CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction. Front Cardiovasc Med. 2022;9:992653. doi:10.3389/fcvm.2022.992653
   PubMedGoogle Scholar
• Yang G, Tan Z, Zhou L, et al. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study. Hypertension. 2020;76(1):51–58. doi:10.1161/HYPERTENSIONAHA.120.15143
   PubMed Web of Science ®Google Scholar
• Tutarel O, Meyer GP, Bertram H, et al. Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle. Int J Cardiol. 2012;154(1):14–16. doi:10.1016/j.ijcard.2010.08.068
   PubMed Web of Science ®Google Scholar
• Zhuang R, Meng Q, Ma X, et al. CD4+FoxP3+CD73+ regulatory T cell promotes cardiac healing post-myocardial infarction. Theranostics. 2022;12(6):2707–2721. doi:10.7150/thno.68437
   PubMed Web of Science ®Google Scholar
• Kumar V, Rosenzweig R, Asalla S, et al. TNFR1 contributes to activation-induced cell death of pathological CD4+ T lymphocytes during ischemic heart failure. JACC. 2022;7(10):1038–1049. doi:10.1016/j.jacbts.2022.05.005
   Google Scholar